Main

type

0 (not classified)

status

21 (imported old-v2, waiting for another import)

review version

1

cleanup version

0

pending deletion

0 (-)

created at

2026-01-18 18:25:03

updated at

2026-01-18 18:25:03

Address

url

https://ir.prothena.com/investors/press-releases/news-details/2024/Prothena-Announces-Bristol-Myers-Squibb-Opt-in-for-Exclusive-Global-License-for-PRX019-the-Second-Program-from-Global-Neuroscience-Research-and-Development-Collaboration/default.aspx

url length

249

url crc

38023

url crc32

3286013063

location type

1 (url matches target location, page_location is empty)

canonical status

2 (missing canonical tag in html)

canonical page id

-

Source

domain id

45918323

domain tld

2211

domain parts

3

originating warc id

6577918

originating url

source type

11 (CommonCrawl)

Server response

server ip

162.159.129.11

Publication date

2025-07-16 05:08:52

Fetch attempts

0

Original html size

67264

Normalized and saved size

33022

Content

title

Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration

excerpt

content

author

updated

1769146390

Text analysis

block type

0

extracted fields

8

extracted bits

title

detected location

0

detected language

1 (English)

category id

-

index version

1

paywall score

0

spam phrases

0

Text statistics

text nonlatin

0

text cyrillic

0

text characters

4593

text words

785

text unique words

339

text lines

36

text sentences

21

text paragraphs

9

text words per sentence

37

text matched phrases

0

text matched dictionaries

0